Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00DSV
|
|||
Former ID |
DIB011990
|
|||
Drug Name |
Polynoma-1
|
|||
Synonyms |
Polyvalent melanoma vaccine, Vaccinoma
Click to Show/Hide
|
|||
Drug Type |
Vaccine
|
|||
Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | |
Company |
Vaccinoma Inc
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | MART-1 melanoma antigen (MLANA) | Target Info | . | [1] |
Melanoma-associated antigen 3 (MAGEA3) | Target Info | . | [1] | |
Tyrosinase (TYR) | Target Info | . | [1] | |
BioCyc | (S)-reticuline biosynthesis | |||
Eumelanin biosynthesis | ||||
L-dopachrome biosynthesis | ||||
KEGG Pathway | Tyrosine metabolism | |||
Riboflavin metabolism | ||||
Metabolic pathways | ||||
Melanogenesis | ||||
Pathwhiz Pathway | Riboflavin Metabolism | |||
Tyrosine Metabolism | ||||
WikiPathways | Dopamine metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | An immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. Polynoma. 2015. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.